The internet and social media have transformed our lives. It has literally opened up a global connection to those with similar interests and passions. In my focused world of patient advocacy for breast health, I meet innumerable women, fervent in their yearly breast cancer screening yet diagnosed with a missed, delayed and advanced stage cancer because of their dense breast tissue. Like me, these women never knew about the impact of dense breast tissue on the reliability of their mammogram until after their diagnosis. Our mission is to correct this fatal flaw in breast cancer screening.

With today’s widespread internet-savvy, purchasers will most likely research a product online first. Modern medical ...

The last two decades have brought a series of changes in medicine, technology and healthcare legislation that have impacted the field of diagnostic imaging and the role of the radiologist. Coupled with these changes, imaging volume is declining1 due to costs as well as concerns over patient radiation exposure.2 This environment often makes it challenging for radiology groups to protect their financial performance and ensure they deliver high-quality studies and readings. Fortunately, advances in imaging and information technology have emerged, helping radiologists increase the utilization of diagnostic imaging and moving the radiologist into a more central role in integrated patient care.3

Precision medicine is not only a buzzword, it is a call to action to radically advance our capabilities in the era of molecular targeted medicine. Positron emission tomography (PET) has firmly established its leading role as a capable oncologic molecular imaging technique over the last two decades, however its technological advances have been modest at best.